Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 777 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Ambit, Teva announce FDA clearance of CEP-32496

The preclinical findings also demonstrate that CEP-32496 possesses potent and sustained anti-tumor activity in xenograft models of melanoma and colon carcinoma. CEP-32496 possesses attractive pharmacokinetic properties upon oral

FDA approves Mylan ANDA for Clopidogrel tablets

The generic version of Sanofi-Aventis’ Plavix is indicated for acute coronary syndrome and for patients with a recent history of myocardial infarction, stroke or established peripheral arterial disease.

Baxter gains approval for ADVATE in China

ADVATE is infused directly into the bloodstream, allowing the body’s blood clotting process to properly function, by temporarily raising the level of factor VIII. With the approval in